Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

474
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
474
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

655
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
655
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

568
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

400
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
400
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years.

European heart journal·2026
Same author

Mitral transcatheter edge-to-edge repair for ventricular secondary mitral regurgitation: do we have enough evidence for its benefit?

European heart journal·2026
Same author

The year in cardiovascular medicine 2025: the top 10 papers in valvular heart disease.

European heart journal·2026
Same author

Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events.

European journal of internal medicine·2025
Same author

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial.

European heart journal·2025
Same author

Refining current risk stratification guidelines for pregnant women with Fontan circulation: lessons from PROFAT registry.

European journal of preventive cardiology·2025
Same journal

Cholesterol Perceptions and Preferences Among Young Adults: A Survey of U.S. Adults Aged 30 to 39 Years.

JACC. Advances·2026
Same journal

Radiomics for the Detection and Prediction of Cancer Therapy-Related Cardiotoxicity.

JACC. Advances·2026
Same journal

Real-World Experience With Mavacamten in SRT-Eligible Obstructive HCM.

JACC. Advances·2026
Same journal

Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry.

JACC. Advances·2026
Same journal

Meteorological and Environmental Factors Associated With Sudden Cardiac Arrest During Marathons in Japan.

JACC. Advances·2026
Same journal

Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.

JACC. Advances·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

4.9K

Pregnancy in Women With Impaired Left Ventricular Function: Data From ROPAC.

Puck N J Peters1, Sahra Ünlütürk1, Avraham Shotan2

  • 1Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands.

JACC. Advances
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

Pregnancy in women with impaired left ventricular function (LVF) poses significant risks, with high rates of heart failure and major adverse cardiac events (MACE). Careful monitoring is crucial for managing these complex pregnancies.

Keywords:
cardiomyopathyheart diseaseheart failurematernal mortalitypregnancy

More Related Videos

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
09:40

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Published on: May 13, 2019

11.2K
Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
10:33

Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography

Published on: February 3, 2014

28.7K

Related Experiment Videos

Last Updated: Feb 28, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

4.9K
Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
09:40

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Published on: May 13, 2019

11.2K
Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography
10:33

Assessment of Right Ventricular Structure and Function in Mouse Model of Pulmonary Artery Constriction by Transthoracic Echocardiography

Published on: February 3, 2014

28.7K

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Pregnancy imposes significant hemodynamic stress, particularly challenging for women with pre-existing heart disease.
  • Impaired left ventricular function (LVF), defined as ejection fraction <40%, presents a high-risk profile during gestation.

Purpose of the Study:

  • To investigate the cardiac, obstetric, and fetal outcomes in pregnant women diagnosed with impaired LVF.
  • To identify risk factors associated with adverse outcomes in this high-risk population.

Main Methods:

  • Analysis of a prospective, international observational cohort (ROPAC) of 251 pregnant women with impaired LVF.
  • Primary endpoint: Major Adverse Cardiac Events (MACE), including mortality, arrhythmias, heart failure, and thromboembolic events.
  • Logistic regression used to identify predictors of poor outcomes.

Main Results:

  • Maternal mortality was 2.4%, with heart failure occurring in 27% and ventricular tachyarrhythmias in 4% of patients.
  • 32% of patients experienced at least one MACE during pregnancy or postpartum.
  • Obstetric complications included preterm birth (27%) and low birthweight (26%).
  • Cardiomyopathy patients faced higher risks: 4.3% mortality and ~40% MACE risk.
  • Pre-pregnancy heart failure symptoms, atrial fibrillation, and NYHA class >II predicted poor cardiac outcomes.

Conclusions:

  • Women with impaired LVF face elevated risks of heart failure, tachyarrhythmias, and premature delivery with low birth weight.
  • Early identification of risk factors like heart failure symptoms and arrhythmias is critical for management.